Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-Exposure Prophylaxis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT04330144
What this trial is testing

Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial)

Who this might be right for
Contact Person From COVID-19 Confirmed Patient
Gangnam Severance Hospital
Early research (Phase 1)Study completedNCT01566877
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers

Who this might be right for
Marburg Hemorrhagic Fever
Sarepta Therapeutics, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT06057064
What this trial is testing

Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19

Who this might be right for
COVID-19, SARS-CoV-2
AstraZeneca 116
Not applicableStudy completedNCT05761509
What this trial is testing

"Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral Risk"

Who this might be right for
HIV Infections
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 226
Not applicableUnknownNCT05438953
What this trial is testing

Follow-up of People at Risk of Monkeypox Infection: a Prospective Cohort Study

Who this might be right for
Monkey PoxMonkey Diseases
Assistance Publique - Hôpitaux de Paris 164
Testing effectiveness (Phase 2)Study completedNCT05886816
What this trial is testing

Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19

Who this might be right for
SARS-CoV InfectionCOVID-19
University of Texas Southwestern Medical Center 122
Large-scale testing (Phase 3)Study completedNCT04478084
What this trial is testing

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland

Who this might be right for
Rabies (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 403
Testing effectiveness (Phase 2)UnknownNCT03259698
What this trial is testing

Optimizing the Delivery of HIV nPEP

Who this might be right for
HIV Infections
Unity Health Toronto 434
Post-approval studies (Phase 4)Study completedNCT01533272
What this trial is testing

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 240
Post-approval studies (Phase 4)Ended earlyNCT01602822
What this trial is testing

Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV

Who this might be right for
HIV
Kenneth H. Mayer, MD 11
Large-scale testing (Phase 3)WithdrawnNCT04397328
What this trial is testing

COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada

Who this might be right for
COVID-19
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Not applicableUnknownNCT06318195
What this trial is testing

Condensed Digital Prolonged Exposure for Individuals Treated Within Somatic Trauma Care.

Who this might be right for
Post Traumatic Stress DisorderAcute Stress Disorder
Karolinska Institutet 250
Post-approval studies (Phase 4)Study completedNCT02991872
What this trial is testing

Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children

Who this might be right for
Virus Diseases
GlaxoSmithKline 150
Large-scale testing (Phase 3)UnknownNCT04597775
What this trial is testing

Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis

Who this might be right for
SARS-CoV Infection
Regional Center for Disease Control and Prevention, Jordan 93
Testing effectiveness (Phase 2)Study completedNCT01228383
What this trial is testing

Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy Adults

Who this might be right for
Rabies
Crucell Holland BV 240
Not applicableLooking for participantsNCT06729632
What this trial is testing

Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss

Who this might be right for
Noise ExposureNoise-induced Hearing LossNoise; Adverse Effect+5 more
Restorear Devices LLC 116
Post-approval studies (Phase 4)Study completedNCT01715636
What this trial is testing

Safety, Tolerability,and Adherence to Co-formulated Tenofovir-emtricitabine-rilpivirine Used as HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men.

Who this might be right for
HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men
Andrew Carr 100
Post-approval studies (Phase 4)Study completedNCT04965662
What this trial is testing

The Role of Home Packs of HIV PEPSE in High Risk Individuals

Who this might be right for
HIV-1-infection
Guy's and St Thomas' NHS Foundation Trust 139
Not applicableStudy completedNCT04829630
What this trial is testing

Immunity Persistence After Abridged Intradermal Rabies PEP

Who this might be right for
Rabies
Institut Pasteur 180
Large-scale testing (Phase 3)Study completedNCT05846568
What this trial is testing

Study to Evaluate GR1801's Efficacy and Safety

Who this might be right for
Rabies Post-exposure Prophylaxis
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 1,200
Next Page